Cuba, that scrappy little Caribbean country that lives in the 1950’s may have an affordable lung cancer cure.
Why does it cost so much to cure or successfully treat a cancer in the USA? Most people who are diagnosed with lung cancer endure expensive and side effect laden therapies, and have surgeries to remove affected tissues.
As a health care provider, I have always wondered why the cancer industry focuses on expensive and convoluted cures, instead of prevention and eradication of the commonality that causes it. In a society that values capitalism and the profits it provides, is there and incentive to cure the disease when treating it is such a great business for all involved? Would Starbucks want to cure you of your coffee addiction? This may actually be the true narrative of what happens when capitalism meets healthcare; a system more about the profits than the people it serves.
In German functional medicine, they believe the ultimate causes are viruses, and they believe that their approach to homeopathy cures these problems. In Cuba, they have developed a cure for lung cancer called Cimavax may be on its way to the USA.
“CIMAvax is called a vaccine because it prompts the immune system to block an attack, but it isn’t preventative in the way a chicken pox vaccine, for example, is. It is a treatment for lung cancer, one that gets the immune system to slow the growth of cancerous cells.”
Read more about this here. Sometimes, a socialist or communistic country can use their government to do great things. Read about Cuba’s recent export that is now undergoing trials here.
Is There a Cure for Cancer Waiting in Cuba?
Life-saving news from the lifted embargo.
BY SARAH RENSE NOV 17, 2016
Cuba is exporting something far more interesting than cigars and rum: a vaccine for cancer. CIMAvax is a lung cancer treatment recently developed in Cuba, where medical research is not dominated by consumer interests””yet. Trials in Cuba found that CIMAvax extended patients’ lives after chemotherapy by three-to-five months longer than those who didn’t receive the vaccine. And last month, it was announced that CIMAvax is making its way to the Roswell Park Cancer Institute in New York for an FDA-approved clinical trial, The New York Times reports.